Immune Thrombocytopenia clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • RAY121 in Immunological Diseases (RAINBOW Trial)

    Sorry, not currently recruiting here

    This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway, after multiple dose administration in patients…

    at UC Irvine

  • Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

    Sorry, in progress, not accepting new patients

    This is a randomized, double-blind study of rilzabrutinib in patients with persistent or chronic ITP, with an average platelet count of <30,000/μL (and no single platelet count >35,000/μL) on two counts at least 5 days apart in the 14 days before…

    at UCLA UCSF

Last updated: